Symptomatic hyperammonemia secondary to recombinant Erwinia asparaginase.

Autor: Martin CE; Department of Pharmacy - Ambulatory Service, Mayo Clinic, Rochester, Minnesota, USA., Kohorst MA; Department of Pediatric and Adolescent Medicine, Division of Pediatric Hematology/Oncology, Mayo Clinic, Rochester, Minnesota, USA., Ferdjallah A; Department of Pediatric and Adolescent Medicine, Division of Pediatric Hematology/Oncology, Mayo Clinic, Rochester, Minnesota, USA., Kalmes JL; Department of Pediatric and Adolescent Medicine, Division of Pediatric Hematology/Oncology, Mayo Clinic, Rochester, Minnesota, USA., Johnson HM; Department of Pediatric and Adolescent Medicine, Division of Pediatric Hematology/Oncology, Mayo Clinic, Rochester, Minnesota, USA., Galardy PJ; Department of Pediatric and Adolescent Medicine, Division of Pediatric Hematology/Oncology, Mayo Clinic, Rochester, Minnesota, USA., Khan SP; Department of Pediatric and Adolescent Medicine, Division of Pediatric Hematology/Oncology, Mayo Clinic, Rochester, Minnesota, USA., Kuhn AK; Department of Pharmacy - Ambulatory Service, Mayo Clinic, Rochester, Minnesota, USA.

Publikováno v: Pediatric blood & cancer [Pediatr Blood Cancer] 2023 May; Vol. 70 (5), pp. e30208. Date of Electronic Publication: 2023 Jan 12.